<DOC>
	<DOCNO>NCT01001793</DOCNO>
	<brief_summary>The Levacor™ Ventricular Assist Device ( VAD ) design mechanical circulatory support heart failure patient . The purpose clinical study determine safety efficacy bridge transplant ( BTT ) cardiac transplant candidate presume non-reversible left ventricular failure .</brief_summary>
	<brief_title>Levacor™ Ventricular Assist Device ( VAD ) Bridge Transplant Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Patient must least 18 year age time VAD implantation . 2 . Listed cardiac transplantation UNOS Status 1A 1B time VAD implantation within 72 hour VAD implantation . 3 . Body Surface Area ( BSA ) 1.2 m2 great . 4 . If female childbearing potential must negative pregnancy test . 5 . Patient sign Informed Consent . 1 . Unacceptable surgical risk accord Principal Investigator . 2 . Intolerance contraindication anticoagulation antiplatelet therapy . 3 . Excessive risk bleeding evidence INR &gt; 2.3 , PTT &gt; 45 sec , platelet count &lt; 50,000 U , unresponsive treatment . 4 . Excessive neurologic risk document TIA within last 3 month stroke within last 6 month . 5 . Evidence follow indicator endorgan dysfunction : total bilirubin &gt; 4 mg/dL , ALT/AST &gt; 3 time upper limit normal , serum creatinine &gt; 3.5 mg/dL . 6 . Fixed pulmonary hypertension recent PVR &gt; 5 Wood unit unresponsive pharmacological intervention . 7 . Severe chronic obstructive pulmonary disease evidence FEV1 &lt; 1.0 L restrictive lung disease prolong ( &gt; 48 hour ) intubation . 8 . Presence mechanical aortic valve convert bioprosthesis VAD implantation . 9 . Planned concomitant surgical procedure aortic valve repair tissue valve placement treat moderate severe aortic insufficiency , tricuspid valve repair , mitral valve repair , critical lesion CABG , LV thrombectomy ( apical ) , closure persistent foramen ovale , atrial septal defect . 10 . Cardiogenic shock secondary acute myocardial infarction . 11 . Presence ongoing mechanical circulatory support intraaortic balloon counterpulsation . 12 . Presence uncontrolled infection . 13 . BMI &gt; 40 kg/m2 . 14 . Significant peripheral vascular disease accompany pain rest , extremity ulceration disable claudication . 15 . Illness , heart disease , would limit survival le 1 year . 16 . Pulmonary embolus &lt; 2 week VAD implant . 17 . Poor/compromising nutritional status judgment Principal Investigator . 18 . Participation another clinical trial , accord Principal Investigator , likely affect Study outcome confound result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>